HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Despina Piatopoulou Selected Research

PVDA protocol

11/2018BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
7/2018Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
9/2017miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Despina Piatopoulou Research Topics

Disease

4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2018 - 11/2015

Drug/Important Bio-Agent (IBA)

1RNA (Ribonucleic Acid)IBA
07/2018

Therapy/Procedure

3PVDA protocol
11/2018 - 09/2017
2Drug Therapy (Chemotherapy)
11/2018 - 11/2015
2Therapeutics
07/2018 - 11/2015